Direxion Daily S&P Biotech Bull 3x Shares

Alternatives

LABU

1301 Avenue of the Americas,28th Floor
New York , NY, 10019

Price

  • $ 109.68 0 % +2.98
    Jul 5, 2024
  • Last Close
  • Net Assets
  • $1B
    Apr 1, 2024
  • 52-Week High/Low
  • $174.12 - $49.6

  • Expense Ratio
  • -

Link

Directors

Jan 16, 2024
  • David Driscoll
  • Kathleen Berkery
  • Carlyle Peake
  • Mary Jo Collins
  • Daniel O'Neill
  • Angela Brickl

Chief Compliance Officer

  • Todd Sherman

Company Name

Holding

More 0 %

Documents

Prospectus

link

Annual Reports

link

Returns +
Q

2024 2023 2022 2021 2020 2019
Q1 8.8% 1289% -56.5% -21.4% -60.8% 82.6%
Q2 -11.2% 20.6% -57% -6.7% 163.6% -15.6%
Q3 - -35.6% 4% -24.9% -9.9% -40.2%
Q4 - 77.3% 0.9% -34.9% 87.5% 85.1%

Returns +
M

J F M A M J J A S O N D
2024 -8.5% 35.8% -12.4% -31.5% 7.8% - - - - - - -
2023 2262.1% -21.3% -25.3% 13.4% 12% -5.1% 2% -18.4% -22.7% -28.6% 41.9% 58%

Returns +
A

    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
    -19.7%1625.2%-80.4%-64.2%74.7%75.3%-57.6%149.1%-62.9%-43.7%5.9%

Alpha LABU and S&P 500

LABU and S&P 500

Chart +